🚀 VC round data is live in beta, check it out!
Luxbright Valuation Multiples
Discover revenue and EBITDA valuation multiples for Luxbright and similar public comparables like Co-Diagnostics, SpectraCure, Redsense Medical, Lucyd and more.
Luxbright Overview
About Luxbright
Luxbright AB is a technology company focusing on developing and commercializing a new generation of X-ray tubes. The company offers X-ray tubes, generators, and future X-ray systems to international system suppliers in order to improve and protect lives by enabling higher resolution X-ray images. The X-ray tubes are a powerful, stable, and cost-effective alternative to conventional X-ray tubes.
Founded
2012
HQ
Employees
12
Website
Sectors
Financials (FY)
EV
$4M
Luxbright Financials
Luxbright reported last fiscal year revenue of $1M and negative EBITDA of ($2M).
In the same fiscal year, Luxbright generated $1M in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).
Luxbright P&L
In the most recent fiscal year, Luxbright reported revenue of $1M and EBITDA of ($2M).
Luxbright expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 85% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (147%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (169%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (171%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Luxbright Stock Performance
Luxbright has current market cap of $5M, and enterprise value of $4M.
Market Cap Evolution
Luxbright's stock price is $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4M | $5M | 0.3% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLuxbright Valuation Multiples
Luxbright trades at 3.0x EV/Revenue multiple, and (2.1x) EV/EBITDA.
Luxbright Financial Valuation Multiples
As of April 8, 2026, Luxbright has market cap of $5M and EV of $4M.
Equity research analysts estimate Luxbright's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Luxbright has a P/E ratio of (2.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV (current) | $4M | XXX | $4M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.8x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.6x | XXX | XXX | XXX |
| P/E | — | XXX | (2.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (1.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Luxbright Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Luxbright Margins & Growth Rates
Luxbright's revenue in the last fiscal year grew by 27%.
Luxbright's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Luxbright Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 27% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (147%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 9% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 253% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Luxbright Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Co-Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| SpectraCure | XXX | XXX | XXX | XXX | XXX | XXX |
| Redsense Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Lucyd | XXX | XXX | XXX | XXX | XXX | XXX |
| ScandiDos | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Luxbright M&A Activity
Luxbright acquired XXX companies to date.
Last acquisition by Luxbright was on XXXXXXXX, XXXXX. Luxbright acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Luxbright
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLuxbright Investment Activity
Luxbright invested in XXX companies to date.
Luxbright made its latest investment on XXXXXXXX, XXXXX. Luxbright invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Luxbright
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Luxbright
| When was Luxbright founded? | Luxbright was founded in 2012. |
| Where is Luxbright headquartered? | Luxbright is headquartered in Sweden. |
| How many employees does Luxbright have? | As of today, Luxbright has over 12 employees. |
| Is Luxbright publicly listed? | Yes, Luxbright is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Luxbright? | Luxbright trades under LXB ticker. |
| When did Luxbright go public? | Luxbright went public in 2020. |
| Who are competitors of Luxbright? | Luxbright main competitors are Co-Diagnostics, SpectraCure, Redsense Medical, Lucyd. |
| What is the current market cap of Luxbright? | Luxbright's current market cap is $5M. |
| What is the current revenue of Luxbright? | Luxbright's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Luxbright? | Current revenue multiple of Luxbright is 3.0x. |
| Is Luxbright profitable? | No, Luxbright is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.